Source Post
The creator highlights Nasus Pharma's (NSRX) proprietary nasal spray technology as a potential needle-free...
Sep 29, 2026
The creator highlights Nasus Pharma's (NSRX) proprietary nasal spray technology as a potential needle-free alternative to the EpiPen for treating anaphylaxis, citing clinical study data and market opportunity.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.